All Stories

  1. Time in range and its association with sudomotor dysfunction in individuals with type 1 diabetes mellitus
  2. Poincaré maps on population-based data of subjects with a confirmatory diagnosis of COVID-19
  3. Factors Associated with Insulin Nonadherence in Type 1 Diabetes Mellitus Patients in Mexico
  4. Empowerment of patients with type 2 diabetes: current perspectives
  5. The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes
  6. Lipid Disorders: Advances in Research and Challenges in Clinical Practice
  7. Fructose consumption is associated with worse renal outcomes
  8. Dyslipidemia in Mexico, a Call for Action
  9. Índices para la evaluación de la resistencia a la insulina en individuos mexicanos sin diabetes
  10. Sucralose decreases insulin sensitivity in healthy subjects: a randomized controlled trial
  11. The Management of Incidental Fatty Liver Found on Imaging. What Do We Need to do?
  12. Identification of a threshold to discriminate fasting hypertriglyceridemia with postprandial values
  13. Insulin Adherence in Type 2 Diabetes in Mexico: Behaviors and Barriers
  14. Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas
  15. Percutaneous muscle biopsy-induced tissue injury causes local endoplasmic reticulum stress
  16. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes
  17. Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms
  18. Non-Nutritive Sweeteners: Evidence on their Association with Metabolic Diseases and Potential Effects on Glucose Metabolism and Appetite
  19. Impact of anthropometric cut-off values in determining the prevalence of metabolic alterations
  20. Metabolic Features of Alcoholic Liver Disease
  21. Effects of the Non-Nutritive Sweeteners on Glucose Metabolism and Appetite Regulating Hormones: Systematic Review of Observational Prospective Studies and Clinical Trials
  22. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome
  23. Topical Administration of Pirfenidone Increases Healing of Chronic Diabetic Foot Ulcers: A Randomized Crossover Study
  24. The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease
  25. Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia
  26. Factors associated with postprandial lipemia and apolipoprotein A-V levels in individuals with familial combined hyperlipidemia
  27. Diurnal Variation in Insulin Sensitivity of Glucose Metabolism Is Associated With Diurnal Variations in Whole-Body and Cellular Fatty Acid Metabolism in Metabolically Normal Women
  28. Effect of tomato consumption on high-density lipoprotein cholesterol level: a randomized, single-blinded, controlled clinical trial
  29. Exercise Increases Serum Fibroblast Growth Factor 21 (FGF21) Levels
  30. Treatment of Metabolic Syndrome Slows Progression of Diabetic Nephropathy
  31. Association of the Metabolic Syndrome and Long-Term Renal Function in Kidney Donors
  32. Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey
  33. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels
  34. HbA1c for the Diagnosis of Diabetes Mellitus in a Developing Country. A Position Article
  35. UKPDS Risk Engine, Decode and Diabetes PHD Models for the Estimation of Cardiovascular Risk in Patients with Diabetes
  36. Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance
  37. The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid Metabolism
  38. Prevalence of Hepatitis C Infection in a Population of Asymptomatic People in a Checkup Unit in Mexico City